Amy
- Quote
-
I feel so fortunate to be able to help support patients and do what I do.
- First Name
- Amy
- Credential
- Nurse Case Manager
Information provided by the Nurse Case Managers is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified and licensed physician or other healthcare provider regarding your medical condition, treatment, and healthcare needs.
I feel so fortunate to be able to help support patients and do what I do.
Being there for patients is the best gift I can ever ask for.
It is a great privilege to support patients during their treatment journey.
The most rewarding part of my role is being in a patient’s corner when they need it.
I am passionate about educating patients and empowering them to manage their disease.
The challenge of patient support is real, and the reward is great.
Empowered patients are more engaged and confident in decision-making regarding their health.
Helping patients is a very rewarding profession, and I was meant to be in it.
I enjoy feeling purposeful in my work with rare disease patients and helping them on their journey.
It is a privilege to feel as though you’ve made a difference in a patient’s journey.
I work to enhance the patient journey effectively and efficiently.
There are 2 options once your doctor has prescribed VYVGART:
Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a symptom tracking journal and other helpful resources.
We’re here for you with My VYVGART Path, a program to help you navigate your treatment journey.
Enter your zip code to look up infusion centers in your area.*
This video series features real people who speak about the impact of living with anti-acetylcholine receptor (AChR) antibody positive gMG—and their experiences with VYVGART for IV infusion.
*Your neurologist and insurance company will determine where you can receive your infusions.
AChR=acetylcholine receptor
Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.
These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.
Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.
VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.
Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.
These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.
Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.
VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.